[e-drug] MHRA BE-studies guideline intravenous use

e-drug
1

E-DRUG: MHRA BE-studies guideline intravenous use
-------------------------------------------------

Dear E-druggers

We are interested in having a copy of the MHRA guidelines for
bioavailability / bioequivalence studies for intravenous preparations. MHRA
is the Medicine and Healthcare products Regulatory Agency of UK. Can anyone
please send the same at the earliest and oblige.

Thanks and regards.

Dr. S. K. Tripathi
Professor in Clinical Pharmacology
Kolkata, India
pharmaintel@vsnl.com

[Moderator: for MHRA guidelines contact the MHRA Information Centre, 10-2,
Market Towers, 1 Nine Elms Lane, London SW8 5NQ, telephone 020-7084 2352,
fax 020-7084 2353 or e-mail info@mhra.gsi.gov.uk A simple search did not
produce such a guideline on the MHRA website http://medicines.mhra.gov.uk/
A question, though: should intravenous preparations not be 100%
bioavailable? WB]

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug